Literature DB >> 20019996

The physician's role and responsibility in reporting adverse drug events in children.

Robert G Peterson1, Chris Turner.   

Abstract

Entities:  

Year:  2003        PMID: 20019996      PMCID: PMC2792643          DOI: 10.1093/pch/8.4.213

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  5 in total

1.  Off-label uses of drugs in children.

Authors:  J L Blumer
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Uses of drugs not described in the package insert (off-label uses).

Authors: 
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

3.  Unlicensed and off-label drug use in an Australian neonatal intensive care unit.

Authors:  Colm P F O'Donnell; Robyn J Stone; Colin J Morley
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

4.  Physician knowledge, attitudes, and behavior related to reporting adverse drug events.

Authors:  A S Rogers; E Israel; C R Smith; D Levine; A M McBean; C Valente; G Faich
Journal:  Arch Intern Med       Date:  1988-07

5.  A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.

Authors:  G W 't Jong; A G Vulto; M de Hoog; K J Schimmel; D Tibboel; J N van den Anker
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

  5 in total
  1 in total

Review 1.  Pharmacovigilance: reporting requirements throughout a product's lifecycle.

Authors:  Sylvia Lucas; Jessica Ailani; Timothy R Smith; Ahmad Abdrabboh; Fei Xue; Marco S Navetta
Journal:  Ther Adv Drug Saf       Date:  2022-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.